Patent Yard Sign in
Canadian application, no grantCanada

System for settling over the counter trades

CA 2486815 A1 · Owner: Cummings, R.J. · Inventors: Goone, David; Cummings, R.J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A system for automatically determining a trade settlement pathway comprising receiving trade pathway preferences from a first and second party with respect to each other (520, 530), wherein the trade is settled through clearing if both parties have available accounts with a clearing firm (525 535) and the , trade satisfies each party~s clearing account credit limitations (540,545); and wherein the trade is settled bilaterally if at least one party does not have an available clearing account or both parties prefer to settle the trade bilaterally, and the trade satisfies each party~s bilateral credit limitations.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 30, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 30, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 30, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 30, 2003
GrantedNo grant recorded
Term endedMay 30, 2023
Patent numberCA 2486815 A1
Classification (IPC)G06Q40/04

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMay 30, 2003Term endedMay 30, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.